日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer

IFITM3-MET相互作用通过激活AKT通路驱动EGFR突变型非小细胞肺癌产生奥希替尼耐药性

期刊:Molecular Cancer
影响因子:27.7
doi:10.1186/s12943-025-02493-6.
Ritsu Ibusuki,Eiji Iwama,Atsushi Shimauchi,Hiromu Kawano,Shun Mizusaki,Satoshi Nakamura,Yui Miyazaki,Yu Inutsuka,Mikiko Hashisako,Taishi Harada,Yuko Tsuchiya-Kawano,Hirono Tsutsumi,Takayuki Nakanishi,Noriaki Nakagaki,Yuichiro Koga,Shinichi Kimura,Shun Mashimoto,Daisuke Shibahara,Kohei Otsubo,Yasuto Yoneshima,Kentaro Tanaka,Yoshinao Oda,Isamu Okamoto
肺癌
细胞生物学
信号转导
肿瘤
EGF
AKT
EGFR
MET
PI3K/Akt
发表日期：2025
文献求助 收藏

Enhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutations.

HER2 突变阳性的非小细胞肺癌中，网格蛋白依赖性内吞作用增强了 HER2 的内化。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03126-x
Shimauchi Atsushi, Iwama Eiji, Ibusuki Ritsu, Tsutsumi Hirono, Shibahara Daisuke, Otsubo Kohei, Yoneshima Yasuto, Tanaka Kentaro, Okamoto Isamu
肺癌
细胞生物学
HER2
发表日期：2025
文献求助 收藏

NECTIN4 regulates the cell surface expression of CD155 in non-small cell lung cancer cells and induces tumor resistance to PD-1 inhibitors.

NECTIN4 调节非小细胞肺癌细胞中 CD155 的细胞表面表达，并诱导肿瘤对 PD-1 抑制剂产生耐药性

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04079-z
Mizusaki Shun, Yoneshima Yasuto, Iwama Eiji, Nakashima Tadayuki, Ibusuki Ritsu, Shibahara Daisuke, Otsubo Kohei, Tanaka Kentaro, Okamoto Isamu
细胞生物学
肿瘤
肺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer

GLORY 研究的长期随访结果：一项针对携带 MET 14 号外显子跳跃突变的东亚非小细胞肺癌患者的古马隆替尼 II 期研究

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-638
Lu, Shun; Yu, Yongfeng; Zhou, Jianya; Li, Xingya; Goto, Koichi; Min, Xuhong; Nishino, Kazumi; Cui, Jiuwei; Wu, Ling; Sakakibara, Jun; Shu, Yongqian; Dong, Xiaorong; Li, Lu; Yoneshima, Yasuto; Zhou, Chengzhi; Li, Xiaoling; Zhang, Yiping; Huang, Dingzhi; Zang, Aimin; Zhang, Wei; Wang, Xiuwen; Zhang, Li; Bai, Chong; Fang, Jian; Cao, Lejie; Zhao, Yanqiu; Yu, Yan; Shi, Meiqi; Zhong, Diansheng; Li, Fugen; Duanmu, Wenhao; Wang, Yibin
肺癌
肿瘤
肿瘤免疫
细胞生物学
MET
发表日期：2025
文献求助 收藏

Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary

索托拉西布与多西他赛治疗既往接受过治疗的KRAS G12C突变型非小细胞肺癌：简明扼要的总结

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2474789
de Langen, Adrianus Johannes; Johnson, Melissa L; Mazieres, Julien; Dingemans, Anne-Marie C; Mountzios, Giannis; Pless, Miklos; Wolf, Jürgen; Schuler, Martin; Lena, Hervé; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J; Ramalingam, Suresh S; Dooms, Christophe; Lindsay, Colin R; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Björn; Waterhouse, David; Paz-Ares, Luis
肺癌
肿瘤
肿瘤免疫
细胞生物学
RAS
发表日期：2025
文献求助 收藏

Remarkable response to crizotinib in a patient with advanced lung adenocarcinoma harboring the MPRIP-ROS1 fusion gene: A case report

克唑替尼治疗携带 MPRIP-ROS1 融合基因的晚期肺腺癌患者疗效显著：病例报告

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2025.102243
Kishikawa, Yasuyuki; Otsubo, Kohei; Shibahara, Daisuke; Shiraishi, Yoshimasa; Yoneshima, Yasuto; Iwama, Eiji; Okamoto, Isamu
MPRIP
肿瘤
肿瘤免疫
RIP
发表日期：2025
文献求助 收藏

Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis

Krebs von den Lungen-6 监测免疫检查点抑制剂诱导的肺炎

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010114
Matsukane, Ryosuke; Nakamura, Shoji; Minami, Haruna; Tsubouchi, Kazuya; Yoneshima, Yasuto; Hata, Kojiro; Yasukochi, Sai; Suetsugu, Kimitaka; Okamoto, Isamu; Hirota, Takeshi
肺炎
免疫/内分泌
发表日期：2024
文献求助 收藏

TP53 gain-of-function mutations promote osimertinib resistance via TNF-α-NF-κB signaling in EGFR-mutated lung cancer

TP53功能获得性突变通过TNF-α-NF-κB信号通路促进EGFR突变型肺癌对奥希替尼的耐药性

期刊:npj Precision Oncology
影响因子:6.8
doi:10.1038/s41698-024-00557-2
Ritsu Ibusuki,Eiji Iwama,Atsushi Shimauchi,Hirono Tsutsumi,Yasuto Yoneshima,Kentaro Tanaka,Isamu Okamoto
肺癌
信号转导
肿瘤
TNF-α
EGF
EGFR
P53
NF-κB
发表日期：2024
文献求助 收藏

Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study

一项随机 II 期研究的最终分析数据和探索性生物标志物分析：奥希替尼联合贝伐珠单抗与奥希替尼单药治疗 EGFR 突变型非鳞状非小细胞肺癌初治患者的疗效比较：WJOG9717L 研究

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100716
Kenmotsu, Hirotsugu; Sakai, Kazuko; Mori, Keita; Kato, Terufumi; Sugawara, Shunichi; Kirita, Keisuke; Yoneshima, Yasuto; Azuma, Koichi; Nishino, Kazumi; Teraoka, Shunsuke; Koyama, Ryo; Masuda, Ken; Hayashi, Hidetoshi; Toyozawa, Ryo; Miura, Satoru; Sato, Yuki; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Nishio, Kazuto; Takahashi, Toshiaki
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review

小细胞肺癌同步放化疗诱发气管纵隔瘘：病例报告及文献综述

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15270
Yamamoto, Yoshihiro; Shibahara, Daisuke; Mori, Taro; Otsubo, Kohei; Shiraishi, Yoshimasa; Yoneshima, Yasuto; Iwama, Eiji; Tanaka, Kentaro; Oda, Yoshinao; Okamoto, Isamu
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏